Cancer Center Grant Announcements
THE OVARIAN CANCER RESEARCH FUND, INC.
The Liz Tilberis Scholars Program
Application Deadline: September 15, 2005
This announcement is directed towards junior faculty with a strong commitment
to an investigative career in the field of ovarian cancer research. The
intent of these awards is to support a substantial time commitment to
research and academic endeavors in ovarian cancer.
Liz Tilberis scholarships will be awarded to three individuals working
in institutions with strong existing ovarian cancer research programs.
Proposals should have enough depth to allow the Liz Tilberis Scholar to
compete for additional funding in the future. Candidates must have an
M.D. or Ph.D degree and should be in their first academic appointment
after having completed their fellowship or post-doctoral training. Each
of the three Liz Tilberis Scholars will receive a three-year grant of
$100,000 per annum. Individuals already in a faculty position and those
who will begin such a position by July 2006 are eligible for this award.
Funding is for direct costs only. The investigators and the institution
must certify that at least 75% of the scholar’s time will be dedicated
to ovarian cancer research. Recipients of the awards will be required
to submit annual progress reports to update the status of their research
throughout the award cycle. For more information visit the Ovarian
Cancer Research Fund website at www.ocrf.org.
Applications are available from Roxy McCann at doni0007@umn.edu
THE OVARIAN CANCER RESEARCH FUND, INC.
The Ovarian Cancer Research Training Programs of Excellence
Application Deadline: September 15, 2005
The Ovarian Cancer Research Training Programs of Excellence award provides
funding for trainees who are working under the supervision of a mentor
who is a recognized leader in the field of ovarian cancer research. Trainees
may be involved in either laboratory, clinical or epidemiology research.
Eligible applicants are clinical fellows or post-doctoral fellows. Awards
will be made to approximately four to five individuals working in institutions
with well-developed ovarian cancer research programs. In addition to the
strength of the research environment and project proposal, selection criteria
include the trainee’s prior academic track record and the likelihood
of them pursuing a research career. Although the trainee may take part
in some non-research activities (e.g. class work, clinical) at least 90%
effort should be devoted to research during the tenure of the OCRF award.
The OCRF research training programs of excellence award provides $75,000.
For more information visit the Ovarian Cancer Research Fund website at
www.ocrf.org. Applications are available
from Roxy McCann at doni0007@umn.edu
AMERICAN CANCER SOCIETY REQUEST FOR APPLICATIONS
Pathogenesis and Treatment of Lymphedema Secondary to the Management of
Breast Cancer
RFA-02-2005,
Letter of Intent due August 15th, 2005
Applications due October 15th, 2005
The American Cancer Society, supported by the Longaberger® Company
is announcing this RFA to investigate the incidence, etiology and new
treatments for secondary lymphedema in human subjects. The purpose of
this RFA is to stimulate research on the modification of morbidity from
lymphedema secondary to treatment for breast cancer and to gain some understanding
of the natural history and effective interventions aimed at minimizing
that morbidity. The scope of this research includes attempts to improve
early diagnosis of affected individuals, the choice and timing of treatment,
the pathophysiology of the disorders of skin and subcutaneous tissue secondary
to chronic lymphedema resulting from breast cancer treatment.
This RFA will use the American Cancer Society targeted Research Scholar
Grant (RSG) award mechanism. The applicant will be solely responsible
for the planning, direction, and execution of the proposed project, which
is not to exceed $150,000 direct plus indirect costs per year a period
of 3 years. It is anticipated that a total of $1,500,000 will be available
for 4 3-4applications selected through the Society’s peer review
system.
http://www.cancer.umn.edu/page/docs/Lymphedema-RFA-FINAL-June05.pdf
CANARY FUND AND THE AMERICAN CANCER SOCIETY POSTDOCTORAL
PROGRAM IN THE EARLY DETECTION OF CANCER
Letter Of Intent: N/A
Application Due Date: October 15, 2005
Canary Fund in partnership with the American Cancer Society has created
a postdoctoral fellowship program focused on studies in the tools and
technologies for developing strategies for the early detection of cancer.
Research should be directed at new approaches to improve clinical methods
for the screening of primary tumors and/or metastases including, but not
limited to research focused in the following areas:
• Minimally invasive strategies for early detection
• Biomarker identification or discovery
• Imaging, including novel molecular imaging strategies
Awards will be 3 years in duration with progressive stipends of $40,000,
$42,000, and $44,000 per year, plus $4,000 per year for institutional
allowance. Based upon the availability of funds and the scientific merit
of the applications, it is anticipated that up to 2 awards will be made.
To restrict funding to full 3 year fellowships, applications will only
be accepted from scientists who, at the time of application, have had
no more than 2 years of research experience beyond their terminal degree
(MD or PhD). Applicants must be US citizens or permanent residents working
with an accomplished mentor at a non-profit institution.
http://www.cancer.umn.edu/page/docs/Canary-F05-RFA-final.pdf
NOTICE OF EXTENSION: PAR-03-148 - CANCER EDUCATION
AND CAREER DEVELOPMENT PROGRAM
NOT-CA-05-024
Release Date: July 29, 2005
The purpose of this Notice is to inform potential applicants that the
expiration date for program announcement PAR-03-148, “ Cancer Education
and Career Development Program” (http://grants.nih.gov/grants/guide/pa-files/PAR-03-148.html),
has been extended. The new expiration date is July 5, 2006.
http://grants.nih.gov/grants/guide/notice-files/NOT-CA-05-024.html
ESTABLISHED INVESTIGATOR AWARD IN CANCER PREVENTION
& CONTROL
PAR-05-145
This is a reissuance of PAR-03-149, which was previously released July
8, 2003.
Letters of Intent Receipt Date(s): Not applicable
Application Submission Dates: February1, June 1, October 1
The NCI Established Investigator Award (K05) provides qualified cancer
research scientists in the fields of cancer prevention, control, behavioral,
and/or population sciences with protected time to devote to research and
to mentoring of new investigators. Candidates must justify their request
for K05 support in terms of need for protected time to devote to research
and mentoring. Candidates must have track records of successful independent
research funding and mentoring. At the time of the K05 award, candidates
must have independent R01 research funding or its equivalent in a research
area related to cancer prevention and control. Candidates for the K05
award may not concurrently apply for or have pending another NIH career
development award. Up to two revisions of a K05 application will be accepted.
The award provides the recipient with annual salary support (up to the
current Federal salary limit) for 25 percent to 50 percent effort, plus
fringe benefits. The award also provides $25,000 per year in research-related
expenses. It is expected that most applicants for the K05 award will request
5 years of funding; requests for K05 support must be for at least 3 years.
The K05 award is renewable one time and for up to an additional 5-year
period. The total amount of funds and the number of K05 grants awarded
will depend upon the quality of applications as determined by the peer
review process, their costs, and available funds.
http://grants.nih.gov/grants/guide/pa-files/PAR-05-145.html
More Information at: http://www.cancer.umn.edu/page/ccmembers/members.html